| RS2037930387 |
FOXP1
|
Health Risk |
Pathogenic |
Intellectual disability-severe speech delay-mild dysmorphism syndrome, Intellectual disability-severe speech delay-mild dysmorphism syndrome |
| RS2037949810 |
FOXP1
|
Health Risk |
Pathogenic |
Intellectual disability-severe speech delay-mild dysmorphism syndrome, Intellectual disability-severe speech delay-mild dysmorphism syndrome |
| RS2037954707 |
GNAO1
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2037985341 |
CIC
|
Health Risk |
Pathogenic |
— |
| RS2037994433 |
PTPN11
|
Health Risk |
Likely pathogenic |
LEOPARD syndrome 1, LEOPARD syndrome 1 |
| RS2038012556 |
CEP290
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2038036994 |
NQO1
|
Health Risk |
Likely pathogenic |
— |
| RS2038071036 |
CIC
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 45 |
| RS2038074697 |
LINS1
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal recessive 27 |
| RS2038103354 |
PTPN11
|
Health Risk |
Pathogenic |
RASopathy, RASopathy |
| RS2038105603 |
PTPN11
|
Health Risk |
Likely pathogenic |
RASopathy, RASopathy |
| RS2038105901 |
PTPN11
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, RASopathy |
| RS2038125958 |
PTPN11
|
Health Risk |
Pathogenic |
RASopathy, RASopathy |
| RS2038127324 |
PTPN11
|
Health Risk |
Pathogenic |
RASopathy, RASopathy |
| RS2038154558 |
PTPN11
|
Health Risk |
Pathogenic/Likely pathogenic |
RASopathy, Noonan syndrome 1 |
| RS2038170208 |
RDH12
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 13, Leber congenital amaurosis 13 |
| RS2038182629 |
RDH12
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 13, Leber congenital amaurosis 13 |
| RS2038190712 |
LOXHD1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2038193754 |
RDH12
|
Health Risk |
Pathogenic/Likely pathogenic |
Leber congenital amaurosis 13, Leber congenital amaurosis 13 |
| RS2038195054 |
RDH12
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 13, Leber congenital amaurosis 13 |
| RS2038196341 |
RDH12
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Leber congenital amaurosis 13 |
| RS2038202226 |
DNMT1
|
Health Risk |
Likely pathogenic |
Pituitary stalk interruption syndrome, Pituitary stalk interruption syndrome |
| RS2038212764 |
LOXHD1
|
Health Risk |
Pathogenic |
— |
| RS2038226312 |
LOXHD1
|
Health Risk |
Pathogenic |
— |
| RS2038231425 |
RDH12
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 13, Leber congenital amaurosis 13 |
| RS2038232008 |
RDH12
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 13, Leber congenital amaurosis 13 |
| RS2038232781 |
RDH12
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 13, Leber congenital amaurosis |
| RS2038232911 |
RDH12
|
Health Risk |
Pathogenic/Likely pathogenic |
Leber congenital amaurosis 13, Leber congenital amaurosis |
| RS2038244158 |
ABCC2
|
Health Risk |
Pathogenic/Likely pathogenic |
Dubin-Johnson syndrome, Dubin-Johnson syndrome |
| RS2038250738 |
GLDN
|
Health Risk |
Likely pathogenic |
Lethal congenital contracture syndrome 11, Lethal congenital contracture syndrome 11 |
| RS2038316193 |
RDH12
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 13, Leber congenital amaurosis 13 |
| RS2038317129 |
RDH12
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 13, Leber congenital amaurosis |
| RS2038332961 |
LOXHD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 77, Autosomal recessive nonsyndromic hearing loss 77 |
| RS2038335853 |
CEP290
|
Health Risk |
Pathogenic |
Nephronophthisis, Joubert syndrome |
| RS2038338161 |
LOXHD1
|
Health Risk |
Pathogenic |
— |
| RS2038340977 |
CEP290
|
Health Risk |
Pathogenic/Likely pathogenic |
Leber congenital amaurosis 10, Bardet-Biedl syndrome 14 |
| RS2038343394 |
ATP8A2
|
Health Risk |
Likely pathogenic |
Cerebellar ataxia, intellectual disability |
| RS2038350104 |
KIAA0586
|
Health Risk |
Pathogenic |
Joubert syndrome 23, Short-rib thoracic dysplasia 14 with polydactyly |
| RS2038398296 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2038398856 |
FANCA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia |
| RS2038399117 |
FANCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group A, Fanconi anemia |
| RS2038407808 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2038407878 |
FANCA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia |
| RS2038408351 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2038409656 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia |
| RS2038409874 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia complementation group A |
| RS2038416963 |
DNMT1
|
Health Risk |
Likely pathogenic |
Autosomal dominant cerebellar ataxia, deafness and narcolepsy |
| RS2038438402 |
FTL
|
Health Risk |
Pathogenic |
Hereditary hyperferritinemia with congenital cataracts, Neuroferritinopathy |
| RS2038438612 |
FTL
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuroferritinopathy, Hereditary hyperferritinemia with congenital cataracts |
| RS2038442836 |
PTPN11
|
Health Risk |
Pathogenic/Likely pathogenic |
RASopathy, Noonan syndrome 1 |
| RS2038452898 |
TRAPPC10
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, Neurodevelopmental disorder with microcephaly |
| RS2038460623 |
KCNJ1
|
Health Risk |
Pathogenic |
— |
| RS2038469040 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS2038470723 |
ABCC2
|
Health Risk |
Pathogenic |
— |
| RS2038474519 |
ABCC2
|
Health Risk |
Pathogenic |
— |
| RS2038474528 |
FANCA
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia |
| RS2038478071 |
FANCA
|
Health Risk |
Likely pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2038478110 |
FANCA
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2038491713 |
ATP8A2
|
Health Risk |
Pathogenic |
Cerebellar ataxia, intellectual disability |
| RS2038495632 |
LOXHD1
|
Health Risk |
Likely pathogenic |
— |
| RS2038495764 |
ATP8A2
|
Health Risk |
Likely pathogenic |
— |
| RS2038511531 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2038512511 |
KIAA0586
|
Health Risk |
Pathogenic |
— |
| RS2038517512 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2038519770 |
FANCA
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2038522097 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2038538013 |
PAFAH1B3
|
Health Risk |
association |
Autism spectrum disorder, Autism spectrum disorder |
| RS2038542991 |
SLC7A7
|
Health Risk |
Likely pathogenic |
Lysinuric protein intolerance, Lysinuric protein intolerance |
| RS2038565518 |
HYDIN
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 5, Primary ciliary dyskinesia 5 |
| RS2038566039 |
USH2A
|
Health Risk |
Likely pathogenic |
— |
| RS2038566220 |
USH2A
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinitis pigmentosa 39 |
| RS2038566435 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2038568675 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2038569132 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2, Usher syndrome type 2 |
| RS2038569690 |
USH2A
|
Health Risk |
Likely pathogenic |
— |
| RS2038571383 |
ITCH
|
Health Risk |
Likely pathogenic |
Syndromic multisystem autoimmune disease due to ITCH deficiency, Syndromic multisystem autoimmune disease due to ITCH deficiency |
| RS2038594225 |
SLC7A7
|
Health Risk |
Pathogenic/Likely pathogenic |
Lysinuric protein intolerance, Lysinuric protein intolerance |
| RS2038606313 |
PTPN11
|
Health Risk |
Pathogenic |
RASopathy, RASopathy |
| RS2038616626 |
LOXHD1
|
Health Risk |
Likely pathogenic |
— |
| RS2038617610 |
CCDC40
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2038617702 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2038618125 |
FANCA
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2038628210 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2038641578 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS2038648611 |
POLR3B
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease, demyelinating |
| RS2038649365 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS2038653435 |
TAF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2038664064 |
SLC7A7
|
Health Risk |
Pathogenic/Likely pathogenic |
Lysinuric protein intolerance, Lysinuric protein intolerance |
| RS2038665417 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Colorectal cancer |
| RS2038667190 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS2038668800 |
CEP290
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 14, Bardet-Biedl syndrome 14 |
| RS2038674067 |
CLCN7
|
Health Risk |
Likely pathogenic |
— |
| RS2038674221 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS2038680566 |
PTPN11
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, Cardiovascular phenotype |
| RS2038684134 |
SLC24A5
|
Health Risk |
Pathogenic |
— |
| RS2038684395 |
SLC24A5
|
Health Risk |
Likely pathogenic |
Oculocutaneous albinism type 6, Oculocutaneous albinism type 6 |
| RS2038687584 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS2038690553 |
SLC7A7
|
Health Risk |
Pathogenic/Likely pathogenic |
Lysinuric protein intolerance, Lysinuric protein intolerance |
| RS2038700262 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS2038701489 |
CLCN7
|
Health Risk |
Likely pathogenic |
Autosomal recessive osteopetrosis 4, Autosomal recessive osteopetrosis 4 |